comparemela.com

Latest Breaking News On - Max planck innovation gmbh - Page 1 : comparemela.com

BiondVax s Strategic Research Collaboration with Max Planck and UMG: Significant progress towards development of innovative nanosized antibodies (NanoAbs) for therapeutic indications in addition to COVID-19

BiondVax's Strategic Research Collaboration with Max Planck and UMG: Significant progress towards development of innovative nanosized antibodies (NanoAbs) for therapeutic indications in addition to COVID-19 - read this article along with other careers information, tips and advice on BioSpace

BiondVax announces Second Quarter 2022 Financial Results and Provides Business Update

BiondVax announces Second Quarter 2022 Financial Results and Provides Business Update

Max-Planck: More start-ups, please!

Germany has a problem: it is still strong in basic research, as recently demonstrated by the successful acquisition of a total of 61 ERC Advanced Grants, which secured the country first place in Europe. Twelve of these grants went to Max Planck researchers. But at the same time, Germany is not in a position to put this horsepower on the road and turn it into successful start-ups and companies, as Thomas Sattelberger, former State Secretary at the Federal Ministry of Education and Research, recently stated in an article in WirtschaftsWoche.  

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.